Cardiovascular disease in late survivors of tetralogy of Fallot: A tertiary care center experience

Elisa Bradley, Jeff Parker, Eric Novak, Philip Ludbrook, Joseph Billadello, Ari Cedars

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Patients with tetralogy of Fallot can survive to late adulthood; however, there are few data on cardiovascular outcomes in this population. We conducted a single-center retrospective analysis of cardiovascular outcomes and risk factors in 208 patients with tetralogy of Fallot to better evaluate the burden of cardiovascular disease in this group. Descriptive statistics were used to determine the prevalence of relevant cardiovascular risk factors and outcomes, including a composite analysis of cardiovascular disease. Rates and mean values from the American Heart Association 2011 Heart Disease and Stroke Statistics Update were used as population estimates for comparison. In tetralogy of Fallot patients, cardiovascular disease prevalence was not different from that found in the general population (40% vs 36%, P=0.3). However, there was significantly more cardiovascular disease in tetralogy of Fallot men aged 20 to 39 years (30% vs 14%, P <0.05) and in tetralogy of Fallot men aged 40 to 59 years (63% vs 29%, P <0.0001). This was due to higher prevalence of coronary disease (12% vs 7%, P <0.05) and heart failure (16% vs 2%, P <0.0001). In particular, the increased prevalence of heart failure (regardless of pulmonary valve disease) accounts for the frequency of cardiovascular disease in tetralogy of Fallot men aged 20 to 59 years. These data support the need to routinely screen young adult male survivors of tetralogy of Fallot for asymptomatic heart failure. Further studies are needed to determine the incidence, severity, and long-term effects of cardiovascular disease in the adult congenital heart disease population.

Original languageEnglish (US)
Pages (from-to)418-423
Number of pages6
JournalTexas Heart Institute Journal
Volume40
Issue number4
StatePublished - Oct 8 2013
Externally publishedYes

Fingerprint

Tetralogy of Fallot
Tertiary Care Centers
Survivors
Cardiovascular Diseases
Heart Failure
Population
Heart Diseases
Pulmonary Valve
Lung Diseases
Coronary Disease
Young Adult
Stroke
Incidence

Keywords

  • Cardiovascular disease
  • Cardiovascular risk factors
  • Congenital heart disease
  • Heart failure
  • Late outcomes
  • Retrospective studies
  • Tetralogy of Fallot

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Cardiovascular disease in late survivors of tetralogy of Fallot : A tertiary care center experience. / Bradley, Elisa; Parker, Jeff; Novak, Eric; Ludbrook, Philip; Billadello, Joseph; Cedars, Ari.

In: Texas Heart Institute Journal, Vol. 40, No. 4, 08.10.2013, p. 418-423.

Research output: Contribution to journalArticle

Bradley, E, Parker, J, Novak, E, Ludbrook, P, Billadello, J & Cedars, A 2013, 'Cardiovascular disease in late survivors of tetralogy of Fallot: A tertiary care center experience', Texas Heart Institute Journal, vol. 40, no. 4, pp. 418-423.
Bradley, Elisa ; Parker, Jeff ; Novak, Eric ; Ludbrook, Philip ; Billadello, Joseph ; Cedars, Ari. / Cardiovascular disease in late survivors of tetralogy of Fallot : A tertiary care center experience. In: Texas Heart Institute Journal. 2013 ; Vol. 40, No. 4. pp. 418-423.
@article{539e327f5d0a4aacb276e7d2ef675ea1,
title = "Cardiovascular disease in late survivors of tetralogy of Fallot: A tertiary care center experience",
abstract = "Patients with tetralogy of Fallot can survive to late adulthood; however, there are few data on cardiovascular outcomes in this population. We conducted a single-center retrospective analysis of cardiovascular outcomes and risk factors in 208 patients with tetralogy of Fallot to better evaluate the burden of cardiovascular disease in this group. Descriptive statistics were used to determine the prevalence of relevant cardiovascular risk factors and outcomes, including a composite analysis of cardiovascular disease. Rates and mean values from the American Heart Association 2011 Heart Disease and Stroke Statistics Update were used as population estimates for comparison. In tetralogy of Fallot patients, cardiovascular disease prevalence was not different from that found in the general population (40{\%} vs 36{\%}, P=0.3). However, there was significantly more cardiovascular disease in tetralogy of Fallot men aged 20 to 39 years (30{\%} vs 14{\%}, P <0.05) and in tetralogy of Fallot men aged 40 to 59 years (63{\%} vs 29{\%}, P <0.0001). This was due to higher prevalence of coronary disease (12{\%} vs 7{\%}, P <0.05) and heart failure (16{\%} vs 2{\%}, P <0.0001). In particular, the increased prevalence of heart failure (regardless of pulmonary valve disease) accounts for the frequency of cardiovascular disease in tetralogy of Fallot men aged 20 to 59 years. These data support the need to routinely screen young adult male survivors of tetralogy of Fallot for asymptomatic heart failure. Further studies are needed to determine the incidence, severity, and long-term effects of cardiovascular disease in the adult congenital heart disease population.",
keywords = "Cardiovascular disease, Cardiovascular risk factors, Congenital heart disease, Heart failure, Late outcomes, Retrospective studies, Tetralogy of Fallot",
author = "Elisa Bradley and Jeff Parker and Eric Novak and Philip Ludbrook and Joseph Billadello and Ari Cedars",
year = "2013",
month = "10",
day = "8",
language = "English (US)",
volume = "40",
pages = "418--423",
journal = "Texas Heart Institute Journal",
issn = "0730-2347",
publisher = "Texas Heart Institute",
number = "4",

}

TY - JOUR

T1 - Cardiovascular disease in late survivors of tetralogy of Fallot

T2 - A tertiary care center experience

AU - Bradley, Elisa

AU - Parker, Jeff

AU - Novak, Eric

AU - Ludbrook, Philip

AU - Billadello, Joseph

AU - Cedars, Ari

PY - 2013/10/8

Y1 - 2013/10/8

N2 - Patients with tetralogy of Fallot can survive to late adulthood; however, there are few data on cardiovascular outcomes in this population. We conducted a single-center retrospective analysis of cardiovascular outcomes and risk factors in 208 patients with tetralogy of Fallot to better evaluate the burden of cardiovascular disease in this group. Descriptive statistics were used to determine the prevalence of relevant cardiovascular risk factors and outcomes, including a composite analysis of cardiovascular disease. Rates and mean values from the American Heart Association 2011 Heart Disease and Stroke Statistics Update were used as population estimates for comparison. In tetralogy of Fallot patients, cardiovascular disease prevalence was not different from that found in the general population (40% vs 36%, P=0.3). However, there was significantly more cardiovascular disease in tetralogy of Fallot men aged 20 to 39 years (30% vs 14%, P <0.05) and in tetralogy of Fallot men aged 40 to 59 years (63% vs 29%, P <0.0001). This was due to higher prevalence of coronary disease (12% vs 7%, P <0.05) and heart failure (16% vs 2%, P <0.0001). In particular, the increased prevalence of heart failure (regardless of pulmonary valve disease) accounts for the frequency of cardiovascular disease in tetralogy of Fallot men aged 20 to 59 years. These data support the need to routinely screen young adult male survivors of tetralogy of Fallot for asymptomatic heart failure. Further studies are needed to determine the incidence, severity, and long-term effects of cardiovascular disease in the adult congenital heart disease population.

AB - Patients with tetralogy of Fallot can survive to late adulthood; however, there are few data on cardiovascular outcomes in this population. We conducted a single-center retrospective analysis of cardiovascular outcomes and risk factors in 208 patients with tetralogy of Fallot to better evaluate the burden of cardiovascular disease in this group. Descriptive statistics were used to determine the prevalence of relevant cardiovascular risk factors and outcomes, including a composite analysis of cardiovascular disease. Rates and mean values from the American Heart Association 2011 Heart Disease and Stroke Statistics Update were used as population estimates for comparison. In tetralogy of Fallot patients, cardiovascular disease prevalence was not different from that found in the general population (40% vs 36%, P=0.3). However, there was significantly more cardiovascular disease in tetralogy of Fallot men aged 20 to 39 years (30% vs 14%, P <0.05) and in tetralogy of Fallot men aged 40 to 59 years (63% vs 29%, P <0.0001). This was due to higher prevalence of coronary disease (12% vs 7%, P <0.05) and heart failure (16% vs 2%, P <0.0001). In particular, the increased prevalence of heart failure (regardless of pulmonary valve disease) accounts for the frequency of cardiovascular disease in tetralogy of Fallot men aged 20 to 59 years. These data support the need to routinely screen young adult male survivors of tetralogy of Fallot for asymptomatic heart failure. Further studies are needed to determine the incidence, severity, and long-term effects of cardiovascular disease in the adult congenital heart disease population.

KW - Cardiovascular disease

KW - Cardiovascular risk factors

KW - Congenital heart disease

KW - Heart failure

KW - Late outcomes

KW - Retrospective studies

KW - Tetralogy of Fallot

UR - http://www.scopus.com/inward/record.url?scp=84884960130&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884960130&partnerID=8YFLogxK

M3 - Article

C2 - 24082371

AN - SCOPUS:84884960130

VL - 40

SP - 418

EP - 423

JO - Texas Heart Institute Journal

JF - Texas Heart Institute Journal

SN - 0730-2347

IS - 4

ER -